🔗 Share this article

Treasury head Rachel Reeves has stated she is preparing "targeted steps to tackle household expense pressures" in the upcoming financial statement.

In comments to media outlets, she stated that lowering price rises is a collective duty of both the administration and the Bank of England.

The UK's price growth is expected to be the most elevated among the G7 developed nations this year and next.

Possible Energy Bill Interventions

It is understood the administration could take action to bring down energy bills, for example by slashing the present 5% level of VAT applied on energy.

An additional approach is to cut some of the policy costs presently added to bills.

Fiscal Constraints and Expert Predictions

The administration will receive the next report from the independent fiscal watchdog, the OBR, on Monday, which will reveal how much room there is for these actions.

The consensus from most analysts is that Reeves will have to announce tax rises or expenditure reductions in order to adhere to her voluntary debt limits.

Previously on the same day, calculations showed there was a twenty-two billion pound deficit for the Treasury chief to fill, which is at the more modest range of forecasts.

"It is a joint task between the central bank and the government to bear down further on some of the drivers of price increases," the Chancellor told reporters in Washington, at the annual meetings of the IMF and World Bank.

Tax Pledges and Global Issues

While a great deal of the focus has been on expected tax increases, the Treasury chief said the most recent data from the OBR had not changed her vow to election pledges not to raise rates on earnings tax, sales tax or National Insurance.

She attributed an "uncertain global environment" with increasing geopolitical and commercial concerns for the fiscal revenue measures, likely to be directed on those "wealthiest."

International Trade Tensions

Commenting on worries about the UK's trade ties with China she said: "Our security interests invariably take priority."

Last week's announcement by Chinese authorities to strengthen export controls on rare earths and other materials that are key for advanced tech manufacturing led American leader Donald Trump to propose an additional 100% import tax on goods from the Asian country, raising the risk of an full-scale commercial conflict between the two global powers.

The US Treasury Secretary labeled the Chinese action "economic coercion" and "a global supply chain power grab."

Asked about accepting the American proposal to join its battle with the Asian nation, the Chancellor said she was "very concerned" by Chinese actions and called on the Chinese government "to avoid restrictions and restrict access."

She said the action was "harmful for the world economy and causes additional obstacles."

"I believe there are sectors where we need to challenge Chinese policies, but there are also valuable prospects to trade with China's economy, including financial services and other areas of the economy. We've got to maintain that balance right."

The Treasury chief also affirmed she was collaborating with international partners "on our own essential resources strategy, so that we are less reliant."

NHS Drug Costs and Funding

The Chancellor also acknowledged that the cost the National Health Service pays for drugs could go up as a result of current negotiations with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and funding.

A number of the world's largest drug companies have said in recent statements that they are either halting or canceling investments in the UK, with some blaming the insufficient payments they are receiving.

Last month, the Science Minister said the cost the health service pays for drugs would have to go up to stop companies and pharmaceutical investment leaving the UK.

Reeves told the BBC: "It has been observed due to the pricing regime, that medical research, innovative medicines have not been provided in the UK in the extent that they are in other EU nations."

"Our aim is to guarantee that patients receiving care from the NHS are can obtain the finest essential treatments in the world. And so we are reviewing these issues, and... seeking to obtain additional investment into Britain."